03:50 PM EST - Labopharm Inc : reported financial results for 2010. Total revenue for fiscal 2010 increased to $29.4 million from $24.6 million for fiscal 2009, within product sales of $16.8 million compared with $18.5 million for fiscal 2009. Net loss was $29.0 million, or $0.42 per share, compared with $26.1 million, or $0.46 per share, for fiscal 2009. Labopharm Inc
shares T.DDS are trading down $0.09 at $0.72.
